Hypoxic Incubation Conditions for Optimized Manufacture of Tenocyte-Based Active Pharmaceutical Ingredients of Homologous Standardized Transplant Products in Tendon Regenerative Medicine

Human fetal progenitor tenocytes (hFPT) produced in defined cell bank systems have recently been characterized and qualified as potential therapeutic cell sources in tendon regenerative medicine. In view of further developing the manufacture processes of such cell-based active pharmaceutical ingredi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeannerat, Annick, Peneveyre, Cédric, Armand, Florence, Chiappe, Diego, Hamelin, Romain, Scaletta, Corinne, Hirt-Burri, Nathalie, de Buys Roessingh, Anthony, Raffoul, Wassim, Applegate, Lee Ann, Laurent, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616528/
https://www.ncbi.nlm.nih.gov/pubmed/34831095
http://dx.doi.org/10.3390/cells10112872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616528/
https://www.ncbi.nlm.nih.gov/pubmed/34831095
http://dx.doi.org/10.3390/cells10112872

Ejemplares similares